Purple Biotech Ltd.
USD1.68
-0.06 (-3.45%)
CEO
Gil Efron
IPO Date
2015-11-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$1.79
Prev. Close
$1.74
Day Low
$1.64
Day High
$1.79
52W Low
$1.42
52W High
$29.00
Market Cap
$0.00B
Volume
0.12M
| -1.5 |
| 31 Dec 2023 | FY | -0.1% | -10.2% | -0.1% | -0.0% | 0.01 | 2.20 | -1131.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -46.2% | -39.7% | 0.01 | 4.71 | -1.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -28.4% | -26.2% | 0.01 | 11.41 | -3.7 |
| 31 Dec 2020 | FY | 100.0% | -2799.9% | -35.3% | -33.4% | 0.01 | 19.14 | -2.4 |
| 31 Dec 2019 | FY | 100.0% | -585.0% | -56.1% | -39.7% | 0.02 | 2.34 | -2.4 |
| 31 Dec 2018 | FY | 100.0% | -520.0% | -49.4% | -35.3% | 0.00 | 2.57 | -1.9 |
| 31 Dec 2017 | FY | 100.0% | -12177.0% | -166.5% | -85.9% | 0.00 | 1.96 | -1.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -90.6% | -81.3% | 0.00 | 11.70 | -1.5 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -4.0% | -3.4% | 0.01 | 1.78 | -0.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -3.4% | -3.2% | 0.00 | 2.88 | -1.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -1.4% | -1.3% | 0.00 | 2.72 | -4.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -1.2% | -1.1% | 0.01 | 2.23 | -6.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -2.3% | -1.9% | 0.01 | 1.27 | -3.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.2% | -6.7% | 0.01 | 1.22 | -1.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.1% | -9.4% | 0.01 | 1.34 | -1.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -14.1% | -10.9% | 0.01 | 2.20 | -1.2 |